Lipitor Lawsuits Mount, as Bernstein Liebhard LLP Notes Publication of New Study Suggesting Link Between Statins like Lipitor and Diabetes

Share Article

The firm is investigating Lipitor lawsuits on behalf of patients who allegedly developed new-onset Type 2 diabetes due to their use of Lipitor.

Free Case Review
The findings of this study add to a growing body of evidence which lends credence to the allegations put forth in hundreds of lawsuits that allege an association between Lipitor and diabetes.

As Lipitor lawsuits ( continue to mount in federal court, Bernstein Liebhard LLP notes the publication of a new study that suggests an association between the use of statin drugs like Lipitor and the development of new-onset Type 2 diabetes. The research, which was published this month in the European Journal of Preventive Cardiology, looked at 14 studies involving some 46,000 patients who were treated with either a statin or a placebo. The study authors surmised that roughly 1 out of 5 cases of diabetes diagnosed among statin users could be associated with the cholesterol-lowering medications. The research team reached this conclusion after finding that 3% of statin patients were diagnosed with Type 2 diabetes after they began treatment, compared to just 2.4% of those in the placebo group.*

“The findings of this study add to a growing body of evidence which lends credence to the allegations put forth in hundreds of lawsuits that allege an association between Lipitor and diabetes,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is currently offering free Lipitor lawsuit consultations to anyone who may have been harmed by this medication.

Lipitor and Diabetes
This new study is not the first to suggest that the use of statins like Lipitor may cause patients to develop Type 2 diabetes. In January 2012, for example, research published in JAMA: Internal Medicine reported that post-menopausal women who take Lipitor may be at an increased risk for developing diabetes. ** Following the publication of that study, the U.S. Food & Drug Administration (FDA) ordered the manufacturers of statins, including Lipitor, to add new information about this potential risk to the products’ labels.

In May 2013, research that appeared in the British Medical Journal reported that people taking Lipitor had a 22 percent higher risk of new-onset diabetes.***

According to court documents, at least 270 Lipitor lawsuits have been filed in a federal multidistrict litigation underway in U.S. District Court, District of South Carolina, all of which claim use of the statin caused patients to develop Type 2 diabetes. Plaintiffs further allege that Pfizer Inc. concealed its knowledge regarding the association between Lipitor and diabetes, and claim that the cautions added to the drug’s label in 2012 remain inadequate. (In re Lipitor (Atorvastatin) Litigation, MDL No. 2502)

Alleged victims of Lipitor diabetes may be entitled to compensation for medical bills, lost wages, and pain and suffering. Find out more about the side effects that may be associated with Lipitor at Bernstein Liebhard LLP’s website. To arrange for a free case review, please call 800-511-5092.

*, European Journal of Preventive Cardiology, March 2014
**, JAMA Internal Medicine, January 2012
***, BMJ, March 2013

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since the list was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website